Summary
The relationship between diabetic nephropathy and an insertion (I)/deletion (D) polymorphism in intron 16 of the angiotensin-converting enzyme (ACE) gene is still under debate. The association of ACE gene polymorphism with nephropathy and retinopathy was therefore examined in 362 Japanese patients with non-insulin-dependent diabetes mellitus (NIDDM) and 105 healthy control subjects. Distribution of the ACE genotype did not differ between healthy control subjects and diabetic patients without complications. However, the frequency of the D allele was significantly higher in the diabetic subjects with nephropathy than in those without (0.32 in normoalbuminuric patients vs 0.44 in albuminuria patients with albuminuria) (χ2=7.7; p=0.006). There was no significant association between ACE genotype and retinopathy. These observations thus demonstrate a significant association of the ACE gene polymorphism with nephropathy, but not with retinopathy, in Japanese patients with NIDDM.
Similar content being viewed by others
Abbreviations
- ACE:
-
Angiotensin-converting enzyme
- IDDM:
-
insulin-dependent diabetes mellitus
- NIDDM:
-
non-insulin-dependent diabetes mellitus
- UAI:
-
urinary albumin index
- PCR:
-
polymerase chain reaction
References
Klein R, Klein BE, Moss S, DeMets DL (1988) Proteinuria in diabetes. Arch Intern Med 148: 181–186
Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in type I (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596
Rettig P, Teutsch S (1984) The incidence of end-stage renal disease in type I and type II diabetes mellitus. Diabetic Nephropathy 3: 26–27
Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE (1992) Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int 41: 731–735
Klein R, Klein BE, Moss SE (1984) The Wisconsin epidemiologic study of diabetic retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520–526
Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy: III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 527–532
Seaquist ER, Goetz FC, Rich S, Barbosa J (1989) Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161–1165
Borch-Johonsen K, Norgaard K, Hommel E et al. (1992) Is diabetic nephropathy an inherited complication? Kidney Int 41: 719–722
Parving HH, Hommel E, Smidt UM (1988) Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ 297: 1086–1091
Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group. N Engl J Med 329:1456–1462
Zatz R, Meyer TW, Rennke HG, Brenner BM (1985) Predominance of haemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 82: 5963–5967
Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925–1930
Anderson S, Rennke HG, Garcia DL, Brenner BM (1989) Short and long term effects of anti-hypertensive therapy in the diabetic rat. Kidney Int 36: 526–536
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343–1346
Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F (1993) Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 290: 33–40
Tiret L, Rigat B, Visvikis S et al. (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51: 197–205
Marre M, Bernadet P, Gallois Y et al. (1994) Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43: 384–388
Schmidt S, Schone N, Ritz E, and the Diabetic Nephropathy Study Group (1995) Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 47: 1176–1181
Tarnow L, Cambien F, Rossing P et al. (1994) Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44(5):489–494
Fujisawa T, Ikegami H, GQ Shen et al. (1995) Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 18: 983–985
Group WS (1985) Report on diabetes mellitus. World Health Organization, Technical Report Series 727, Geneva
Gatling W, Knight C, Mullee MA, Hill RD (1988) Microalbuminuria in diabetes; a population study of the prevalence and an assessment of three screening tests. Diabet Med 5: 343–347
Cohen DL, Close CF, Viberti GC (1987) The variability of overnight urinary albumin excretion on insulin-dependent diabetic and normal subjects. Diabet Med 4: 437–440
Tuji K, Aizawa M, Sasazuki T (1992) Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique, vol 1. Oxford University Press, Oxford, pp 397–419
Lindpaintner K, Pfeffer MA, Kreutz R et al. (1995) A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemie heart disease. N Engl J Med 332: 706–711
Lee EJ (1994) Population genetics of the angiotensin-converting enzyme in Chinese. Br J Clin Pharmacol 37: 212–214
Nomura H, Koni I, Michishita Y, Morise T, Takeda R (1994) Angiotensin-converting enzyme gene polymorphism in haemodialysis patients. Lancet 343: 482–483
Mogensen C (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356–360
Jarrett R, Viberti C, Argyropoulos A (1984) Microalbuminuria predicts mortality in non-insulin dependent diabetes. Diabet Med 1:17–19
Schmiz A, Vaeth M (1988) Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med 5:126–134
Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G (1992) Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 41: 736–741
Cambien F, Poirier O, Lecerf L et al. (1993) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641–644
Tiret L, Kee F, Poirier O et al. (1993) Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 341: 991–992
Zhao Y, Higashimori K, Higaki J et al. (1994) Significance of the deletion polymorphism of the angiotensin converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens Res 17: 55–57
Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 8287: 1430–1432
Mangili R, Bending JJ, Scott G, Li-LK, Gupta A, Viberti G (1988) Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 318: 146–150
Herman WH, Prior DE, Yassine MD, Weder AB (1993) Nephropathy in NIDDM is associated with cellular markers for hypertension. Diabetes Care 16: 815–818
Cordonnier DJ, Zmirou D, Benhamou PY, Halimi S, Ledoux F, Guiserix J (1993) Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetes mellitus. The case of mainland France and of overseas French territories. Diabetologia 36: 1109–1112
Kikkawa R, Arimura T, Haneda M et al. (1993) Current status of type 2 (non-insulin-dependent) diabetic subjects on dialysis therapy in Japan. Diabetologia 36: 1105–1108
Marian AJ, Yu QT, Workman R, Greve G, Roberts R (1993) Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342: 1085–1086
Ballard DJ, Humphrey LL, Melton LJ III et al. (1988) Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 37: 405–412
Sasaki A, Horinouchi N, Hasegawa K, Uehara M (1986) Risk factors related to the development of persistent albuminuria among diabetic patients observed in a long-term follow-up. J of the Jpn Diabetes Soc 29: 1017–1023
Kunzelman CL, Knowler WC, Pettitt DJ, Bennett PH (1989) Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians. Kidney Int 35: 681–687
Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501
Parving HH, Larsen M, Hommel E, Lund-Andersen H (1989) Effect of anti-hypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia 32: 440–444
Ferrari-Dileo G, Davis EB, Anderson DR (1987) Angiotensin binding sites in bovine and human retinal blood vessels. Invest Ophthalmol Vis Sci 28:1747–1751
Fernandez LA, Twickler J, Mead A (1985) Neovascularization produced by angiotensin II. J Lab Clin Med 105:141–145
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Doi, Y., Yoshizumi, H., Yoshinari, M. et al. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 39, 97–102 (1996). https://doi.org/10.1007/BF00400419
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400419